Reaction of 2-aminobenzamide analogs and 2-aminothiophenol with ethyl 3-ethoxymethylene-2,4-dioxovalerate. Synthesis of pyrrolo[1,2-α]quinazoline and pyrrolo[1,2-a]benzothiazoline derivatives

The reaction of ethyl 3-ethoymethylene-2,4-dioxovalerate (EMDV) ( 1 ) with 2-aminobenzamide ( 2 ), 2-aminobenzthioamide ( 3 ), 2-aminobenzmethylamide ( 4 ) and 3-amino-2-methyl- or phenylpyrazole-4-carbox-amides ( 6 and 7 ) produced ethyl 3-aminomethylene-2,4-dioxovalerates ( 10, 15, 16, 18 and 19 ), which led to pyrrolo[1,2-a]quinazoline-1,5-diones ( 11, 22 and 23 ) and pyrrolo[1,2-a]pyrazolo[4,3-e]pyrimidine-1,5-diones ( 24 and 25 ) under the acidic condition, respectively. Analogously, 2-aminothiophenol reacted with 1 to give 21 , which was subsequently derived to pyrrolo[1,2-a]benzothiazolin-l-one ( 26 ) under the neutral condition. Furthermore, we prepared the heterocyclic steroidal molecules ( 41, 43, 45, 47, 49 and 51 ) by condensation of 11 and 26 with hydrazine, methylhydrazine and phenylhydrazine.     

Preparation of end‐π‐allylnickel macroinitiator from poly(ethylene glycol) allenyl methyl ether and its application to the living coordination polymerization of isonitriles

An end‐π‐allylnickel macroinitiator ( 3 ) was prepared by the reaction of poly(ethylene glycol) allenyl methyl ether with an excess amount (5 equiv) of [(π‐allyl)NiOCOCF₃]₂ ( 1 ) in the presence of PPh₃ ([PPh₃]/[ 1 ] = 1). The resulting macroinitiator was used as an initiator for the polymerization of 1‐phenylethyl isonitrile ( 4a ) to give a block copolymer [poly(ethylene glycol)‐block‐poly( 4a )]. The molecular weight and composition of the block copolymers were controlled by the molecular weight of 3 and the ratio of 4a to 3 . © 2001 John Wiley & Sons, Inc. J Polym Sci A: Polym Chem 39: 495–499, 2001     

Rhodium-catalyzed carbonyl allylations by allylic alcohols with tin(II) chloride

Rhodium complexes such as [RhCl(cod)]₂, [Rh(cod)₂]BF₄, and [Rh(cod)(CH₃CN)₂]BF₄ function as catalysts for carbonyl allylations by allylic alcohols with 1 equimolar amount of tin(II) chloride to each allylic alcohol and aldehyde in THF at 50 °C to produce the corresponding homoallylic alcohols.     

Titanium and Zirconium Complexes with Non‐Salicylaldimine‐Type Imine–Phenoxy Chelate Ligands: Syntheses,Structures, and Ethylene‐Polymerization Behavior

New Ti and Zr complexes that bear imine–phenoxy chelate ligands, [{2,4‐di‐tBu‐6‐(RCH=N)‐C₆H₄O}₂MCl₂] ( 1 : M=Ti, R=Ph; 2 : M=Ti, R=C₆F₅; 3 : M=Zr, R=Ph; 4 : M=Zr, R=C₆F₅), were synthesized and investigated as precatalysts for ethylene polymerization. ¹H NMR spectroscopy suggests that these complexes exist as mixtures of structural isomers. X‐ray crystallographic analysis of the adduct 1 ?HCl reveals that it exists as a zwitterionic complex in which H and Cl are situated in close proximity to one of the imine nitrogen atoms and the central metal, respectively. The X‐ray molecular structure also indicates that one imine phenoxy group with the syn C?N configuration functions as a bidentate ligand, whereas the other, of the anti C?N form, acts as a monodentate phenoxy ligand. Although Zr complexes 3 and 4 with methylaluminoxane (MAO) or [Ph₃C]⁺[B(C₆F₅)₄]^?/AliBu₃ displayed moderate activity, the Ti congeners 1 and 2 , in association with an appropriate activator, catalyzed ethylene polymerization with high efficiency. Upon activation with MAO at 25 °C, 2 displayed a very high activity of 19900 (kg PE) (mol Ti)^?1 h^?1, which is comparable to that for [Cp₂TiCl₂] and [Cp₂ZrCl₂], although increasing the polymerization temperature did result in a marked decrease in activity. Complex 2 contains a C₆F₅ group on the imine nitrogen atom and mediated nonliving‐type polymerization, unlike the corresponding salicylaldimine‐type complex. Conversely, with [Ph₃C]⁺[B(C₆F₅)₄]^?/AliBu₃ activation, 1 exhibited enhanced activity as the temperature was increased (25–75 °C) and maintained very high activity for 60 min at 75 °C (18740 (kg PE) (mol Ti)^?1 h^?1). ¹H NMR spectroscopic studies of the reaction suggest that this thermally robust catalyst system generates an amine–phenoxy complex as the catalytically active species. The combinations 1 /[Ph₃C]⁺[B(C₆F₅)₄]^?/AliBu₃ and 2 /MAO also worked as high‐activity catalysts for the copolymerization of ethylene and propylene.     

Functionalization of polymers: Epoxidation of polyolefins

In order to produce a polymer with an epoxy group, the epoxidation of the polyolefins poly(ethylene-co-1,9-decadiene) (PED) and polybutadiene (PB) was investigated. For these reactions, in situ generated peroxy acid was most effective and convenient. Among them an H₂O₂–formic acid system gave the best result. The reactivity of PB showed the dependency on the microstructure. The reactivity of the double bond is trans>cis> vinyl(pendant) and the selectivity for the epoxidation is cis∼vinyl(pendant)≫trans.     

The effect of spin multiplicity on the photochemical reaction of a 2-vinylnaphthalene-dichloromaleic anhydride system

Research on Chemical Intermediates - The photochemical reaction of a 2-vinylnaphthalene — dichloromaleic anhydride system has been studied in order to elucidate the correlation between the...     

Writing of crystal line patterns in glass by laser irradiation

We examined the laser-induced crystallization to form the fresnoite type Ba₂TiGe₂O₈ crystal line patterns in transition metal ion doped BaO–TiO₂–GeO₂ glass. Ba₂TiGe₂O₈ crystal line was written in 0.6FeO–33.3BaO–16.7TiO₂–50GeO₂ glass by continuous wave yttrium–aluminum–garnet (YAG) laser irradiation. We obtained polarization dependence of Raman spectra in crystal line pattern. Second harmonic generation (SHG) indicated unique fringe patterns from Ba₂TiGe₂O₈ crystal lines.     

Advances in quantum dots for classical and non-classical light sources Invited Paper

Recent advances in quantum dots (QDs) for classical and non-classical light sources are presented. We have established metal organic chemical vapor deposition (MOCVD) technology for InAs-based QD lasers at 1.3 μm and achieved ultralow threshold in QD lasers with photonic crystal (PhC) nanocavity. In addition, single photon emitters at 1.55/μm, GaN-based single photon sources operating at 200 K, and high-Q PhC nanocavity have been demonstrated.     

Electron acceleration in an ultraintense-laser-illuminated capillary

An ultraintense laser injected a 10 J of power at 1.053 microm in 0.5 ps into a glass capillary of 1 cm long and 60 microm in diameter and accelerated plasma electrons to 100 MeV. One- and two-dimensional particle codes describe wakefields with 10 GV/m gradient excited behind the laser pulse, which are guided by a plasma density channel far beyond the Rayleigh range. The blueshift of the laser spectrum supports that a plasma of 10(16) cm(-3) is inside the capillary. A bump at the high energy tail suggests the electron trapping in the wakefield.     

Synthesis of eosinophil infiltration inhibitors with antihistaminic activity

A series of [1, 2, 4]triazolo[1, 5-b]pyridazines (5) and imidazo[1, 2-b]pyridazines (6) having cyclic amines was synthesized and evaluated for antihistaminic activity and inhibitory effect on eosinophil infiltration. When a piperidine or a piperazine containing a benzhydryl group and a suitable spacer was incorporated at the 6-position, the fused pyridazines were found to exhibit both antihistaminic activity and an inhibitory effect on eosinophil chemotaxis. Above all, 6a showed potent antihistaminic activity, but little blockade of central H(1) receptors in contrast with its complete blockade of peripheral H(1) receptors as determined by an ex vivo binding assay. Furthermore, 6a inhibited eosinophil infiltration of the skin caused by a topical antigen challenge in sensitized guinea pigs, while an antihistamine terfenadine was not effective. After the pharmacokinetic study, 6a was found to be rapidly hydrolyzed to 6o, which was also orally active. Compound 6o, 2-[6-[[3-[4-(diphenylmethoxy)piperidino]propyl]amino]imidazo[1, 2-b]pyridazin-2-yl]-2-methylpropionic acid dihydrate (TAK-427), having both antihistaminic and antiinflammatory activity, is currently undergoing clinical trials as a therapeutic agent for atopic dermatitis and allergic rhinitis.